Muscle relaxants may boost oxygen in severe COVID-19 lung failure
NCT ID NCT04922814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving muscle relaxants along with sedation helps improve oxygen levels in patients with severe COVID-19 lung failure (ARDS) who need a breathing machine. Forty adults were enrolled. The goal was to see if this approach could reduce complications and improve survival in the ICU.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICU-ACQUIRED WEAKNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assiut university, faculty of medicine, anesthesia and ICU and pain management department
Asyut, Asyut Governorate, 71515, Egypt